↑ 薬物リストへ　← 戻る

Ain457a    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
271強直性脊椎炎1

271. 強直性脊椎炎　［臨床試験数：531，薬物数：343（DrugBank：66），標的遺伝子数：41，標的パスウェイ数：141］
Searched query = "Ankylosing spondylitis", "Spondylarthritis ankylopoietica"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 531 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01109940
(ClinicalTrials.gov)		April 201022/4/2010Safety and Tolerability of AIN457 in Adults (18-65 Years) With Moderate to Severe Ankylosing SpondylitisAn Open Label Non-randomized Extension Study to Evaluate the Safety and Tolerability of AIN457 (Anti Interleukin-17 Monoclonal Antibody) in Patients With Moderate to Severe Ankylosing SpondylitisAnkylosing SpondylitisBiological: AIN457ANovartis PharmaceuticalsNULLCompleted18 Years65 YearsBoth39Phase 2United States;Germany;Netherlands;United Kingdom